Allergies News and Research

Latest Allergies News and Research

Scientists shed light on runny nose

Scientists at the University of Colorado School of Medicine have shed light on one of the most common of ailments - the runny nose.

11 Apr 2014

Researchers discover tumor suppressor gene folliculin essential to normal lung function in BHD patients

11 Apr 2014

Scientists identify enzyme that could be a useful target in treating asthma, cancer

In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.

11 Apr 2014

Researchers discover mechanism that control normal lung function in patients with BHD syndrome

Researchers at Penn Medicine have discovered that the tumor suppressor gene folliculin (FLCN) is essential to normal lung function in patients with the rare disease Birt-Hogg-Dube (BHD) syndrome, a genetic disorder that affects the lungs, skin and kidneys. Folliculin's absence or mutated state has a cascading effect that leads to deteriorated lung integrity and an impairment of lung function, as reported in their findings in the current issue of Cell Reports.

11 Apr 2014

NextGen earns ONC 2014 Edition criteria certification for Emergency Department Solution

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today that NextGen® Emergency Department Solution version 6.0 is compliant with the ONC 2014 Edition criteria and was certified as an electronic health record (EHR) Module on March 7, 2014 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ACB, in accordance with the applicable Hospital certification criteria adopted by the Secretary of Health and Human Services.

10 Apr 2014

Genkyotex’s GKT137831 reverses lung fibrosis in new model of idiopathic pulmonary fibrosis

Genkyotex, the leading developer of selective NOX enzyme inhibitors, announced today the publication of data showing that GKT137831, a first in class NOX1 and 4 inhibitor, was able to reverse lung fibrosis associated with aging in a new model of idiopathic pulmonary fibrosis.

10 Apr 2014

NIH study could offer clues for developing new antiviral treatments

A National Institutes of Health study reports that a rare genetic disease, while depleting patients of infection-fighting antibodies, may actually protect them from certain severe or recurrent viral infections.

10 Apr 2014

Food experts to discuss pros and cons of GM crops at Food Integrity and Traceability Conference

One of the world's most contentious food issues - Genetically Modified (GM) crops - will be debated by some of the world's leading authorities on the subject at Queen's University Belfast today (Wednesday day 9 April).

9 Apr 2014

Scientists seek broad, versatile countermeasures effective against several kinds of viruses, other pathogens

A group of University of Washington scientists is seeking broad, versatile countermeasures effective against several different kinds of viruses and other pathogens. The investigators are part of a national push for faster responses to unexpected infectious agents.

9 Apr 2014

Access provides update on new formulation of anti-inflammatory drug amlexanox

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions of the esophagus.

8 Apr 2014

Food allergies are closely linked to spring allergies, says allergist

The Midwest's high tree pollen count is primarily birch and oak, bad news for carrot, celery and almond lovers. "It's healthy if certain foods make your mouth water but it is unhealthy if foods make your nose run or your gums and throat itch," says Joseph Leija, MD, allergist who performs the Gottlieb Allergy Count, the official allergy count for the Midwest.

8 Apr 2014

Research roundup: Mental health parity; nurses' workload; can restaurants reduce portion size?

Historically, health insurance covered mental health care differently than other medical care. Recent laws have begun bringing them into balance. ... Congress passed the Mental Health Parity and Addiction Equity Act (MHPAEA) in 2008. ... the MHPAEA applied to large group health plans, both fully and self-insured, and included a cost exemption.

7 Apr 2014

New insights provide novel therapeutic approach against cancer

A major discovery that brings a new drug target to the increasingly exciting landscape of cancer immunotherapy was published yesterday by researchers from La Jolla Institute for Allergy and Immunology and their collaborators from other institutes.

7 Apr 2014

New "3D" method could reduce the need for animal testing

To determine whether new medicines are safe and effective for humans, researchers must first test them in animals, which is costly and time-consuming, as well as ethically challenging.

3 Apr 2014

Sanaria receives 2014 Vaccine Industry Excellence Award for "Best Prophylactic Vaccine"

Sanaria received the 2014 Vaccine Industry Excellence Award for the "Best Prophylactic Vaccine" at a ceremony held March 25 in Washington DC during the 14th World Vaccine Congress.

3 Apr 2014

Study finds that stress can make allergies worse

Stress doesn't cause allergies, but easing your mind might mean less allergy flare-ups this spring. According to a study published in the April issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology, allergy sufferers with persistent stress experience more allergy flares.

2 Apr 2014

FDA approves ORALAIR sublingual allergy immunotherapy tablet

GREER Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration has approved ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet.

2 Apr 2014

Biogen Idec's ALPROLIX receives FDA approval for hemophilia B treatment

Today Biogen Idec announced that the U.S. Food and Drug Administration has approved ALPROLIX [Coagulation Factor IX (Recombinant), Fc Fusion Protein], the first recombinant, DNA derived hemophilia B therapy with prolonged circulation in the body.

29 Mar 2014

Guidelines for treating paracetamol overdoses cost millions of pounds per year, say researchers

Strict guidelines for treating paracetamol overdoses - introduced 18 months ago - are costing the NHS millions of pounds a year, researchers claim.

27 Mar 2014

Study: Guinea pigs and mice can be replaced with non-animal skin sensitization method

Guinea pigs and mice can be replaced with a non-animal skin sensitization method that uses a human-derived skin model, according to a study presented today by the PETA International Science Consortium, Ltd., at the Society of Toxicology's annual meeting.

27 Mar 2014

Allergies News and Research

Latest Allergies News and Research

Scientists shed light on runny nose

Researchers discover tumor suppressor gene folliculin essential to normal lung function in BHD patients

Scientists identify enzyme that could be a useful target in treating asthma, cancer

Researchers discover mechanism that control normal lung function in patients with BHD syndrome

NextGen earns ONC 2014 Edition criteria certification for Emergency Department Solution

Genkyotex’s GKT137831 reverses lung fibrosis in new model of idiopathic pulmonary fibrosis

NIH study could offer clues for developing new antiviral treatments

Food experts to discuss pros and cons of GM crops at Food Integrity and Traceability Conference

Scientists seek broad, versatile countermeasures effective against several kinds of viruses, other pathogens

Access provides update on new formulation of anti-inflammatory drug amlexanox

Food allergies are closely linked to spring allergies, says allergist

Research roundup: Mental health parity; nurses' workload; can restaurants reduce portion size?

New insights provide novel therapeutic approach against cancer

New "3D" method could reduce the need for animal testing

Sanaria receives 2014 Vaccine Industry Excellence Award for "Best Prophylactic Vaccine"

Study finds that stress can make allergies worse

FDA approves ORALAIR sublingual allergy immunotherapy tablet

Biogen Idec's ALPROLIX receives FDA approval for hemophilia B treatment

Guidelines for treating paracetamol overdoses cost millions of pounds per year, say researchers

Study: Guinea pigs and mice can be replaced with non-animal skin sensitization method

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Allergies News and Research

Latest Allergies News and Research

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Newsletters you may be interested in